Cargando…
Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease
There are conflicting data regarding the use of hydroxychloroquine (HCQ) in COVID-19 hospitalized patients. The objective of this study was to assess the efficacy of HCQ in increasing SARS-CoV-2 viral clearance. Hospitalized adult patients with confirmed SARS-CoV-2 infection were retrospectively inc...
Autores principales: | Mallat, Jihad, Hamed, Fadi, Balkis, Maher, Mohamed, Mohamed A., Mooty, Mohamad, Malik, Asim, Nusair, Ahmad, Bonilla, Maria-Fernanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769326/ https://www.ncbi.nlm.nih.gov/pubmed/33350752 http://dx.doi.org/10.1097/MD.0000000000023720 |
Ejemplares similares
-
Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness
por: Blair, Janis E., et al.
Publicado: (2021) -
A retrospective analysis from a single center for 60 COVID-19 patients with asymptomatic, mild to moderate, and severe conditions in Wuxi, China
por: Huang, Jiehui, et al.
Publicado: (2021) -
Sputum characteristics and airway clearance methods in patients with severe COVID-19
por: Wang, Yu, et al.
Publicado: (2020) -
Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis
por: Liu, Yan, et al.
Publicado: (2020) -
Factors associated with clearance of hepatitis B virus surface antigen in patients infected with human immunodeficiency virus
por: Tsutsumi, Takeya, et al.
Publicado: (2020)